The recent controversy about a new treatment for multiple sclerosis (MS) has raised questions about the role of patients and politicians in determining health research priorities. In the past, the scientific community has generally determined what research is conducted. However the public is increasingly demanding that they be involved in setting research priorities - the best ways of doing so are currently being debated.